Categories
- About MIMS Ireland
- New Products
- New Presentations
- New this Month
- Discontinued Products
- New Clinical Evidence
- Clinical Specials
- Irish Medicines Board
- Medicines and Sport
Archives
- December 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
Tagcloud
ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome
MIMS Ireland: September 2008
Focus on Rheumatoid Arthritis
01 September 2008 | Clinical Specials
Rheumatoid arthritis (RA) is a chronic inflammatory disease among the autoimmune disorders. It is a progressive disabling condition characterised by inflammation of the synovial tissue of the joints with an increase in the number of synovial cells (hyperplasia), infiltration by... Read more
Antidepressants – Update on suicidal thoughts and behaviour
01 September 2008 | Irish Medicines Board
Further to previous articles regarding the risk of suicidal behaviours associated with use of antidepressants, most recently in relation to children and adolescents (Drug Safety Newsletter -Issue 21, 2006), a comprehensive review of available clinical trial data for individual antidepressants... Read more
New data on Ebixa efficacy in moderate to severe AD
01 September 2008 | New Clinical Evidence
New data analysis shows that memantine (Ebixa) is effective in treating and preventing specific behavioural symptoms associated with moderate to severe Alzheimer's disease (AD), with benefits seen for agitation/aggression and delusions at week 12 and 24.... Read more
Leonore
01 September 2008 | New Products
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredients: Levonorgestrel 100mcg, ethinylestradiol 20mcg. Description: White round biconvex coated tablet. Presentation: 3 × 21, €9.00 (1 month 21, €3.00). Indications: Oral contraception.... Read more
Toviaz
01 September 2008 | New Products
Company: Pfizer Healthcare Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Fesoterodine 4mg, 8mg. Description: Light blue or blue, oval, biconvex, film-coated, prolonged-release tablets, engraved FS or FT on one side, respectively. Presentation: 4mg-28; 8mg-28. Indications: Symptoms (increased urinary... Read more
Tredaptive
01 September 2008 | New Products
Company: Merck Sharp & Dohme Ireland (Human Health) Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredients: Nicotinic acid, 1000mg; laropiprant, 20mg. Description: Capsule shaped, white to off white modified-release tablets, with 552 debossed on one side. Presentation: 28, €16.79;... Read more
Stalevo
01 September 2008 | New Presentations
Company: Orion Pharma (Ireland) Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredients: Levodopa, 200mg; carbidopa, 50mg; entacapone, 200mg. Description: Dark brownish red, oval film-coated tablets marked with LCE 200 on one side. Presentation: 100, €103. Indications: Parkinson’s disease and... Read more
Solpadeine capsules - New additional pack size available on GMS
01 September 2008 | New this Month
GlaxoSmithKline Consumer Healthcare (Ireland) Ltd are pleased to announce that Solpadeine Capsules are now available in an additional pack size – 32s. This new pack size will be reimbursed under the GMS scheme from the 1st of September.... Read more
Discontinuations in the Canesten range
01 September 2008 | Discontinued Products
Bayer HealthCare Consumer Care wishes to inform you that, due to internal range rationalisation, the following products have been discontinued: Canesten Solution 20ml, Canesten Dermalogical Powder, Canesten Internal Cream.... Read more
Discontinuation of Clonamp 500mg 500-pack
01 September 2008 | Discontinued Products
Clonmel Healthcare Ltd wish to inform you that Clonamp 500mg 500 pack has been discontinued. Clonamp 250mg (100 pack) Clonamp 500mg (100 pack) Clonamp 125mg Suspension and Clonamp 250mg Suspension remain on the market.... Read more
Discontinuation of Prosobee
01 September 2008 | Discontinued Products
Mead Johnson Nutritionals wish to inform you that the supply of Prosobee (Soya Infant Formula) will be discontinued in 2 months. This decision has been influenced by market trends and clinical recommendations. Mead Johnson Nutritionals no longer participate in this... Read more
Discontinuation of Raptiva single pack
01 September 2008 | Discontinued Products
Merck Serono wish to inform you that supplies of Raptiva 125mg vial single packs are no longer available. Raptiva 125mg is now only available in a 4 vial pack size. This decision has been made due to the 4 pack... Read more
Discontinuation of Zenapax
01 September 2008 | Discontinued Products
Roche Products (Ireland) Ltd wish to inform you of the discontinuation of Zenapax 5mg/ml concentrate for solution for infusion. Due to low demand, marketing will cease permanently at the end of December 2008 and stock remaining in circulation should be... Read more
